Conception and bicentric validation of the proSCANNED score, a simplified bedside prognostic score for Heart Failure patients

[1]  F. Roubille,et al.  Evaluation of the sST2-guided optimization of medical treatments of patients admitted for heart failure, to prevent readmission: Study protocol for a randomized controlled trial. , 2018, Contemporary Clinical Trials.

[2]  M. Komajda,et al.  Quality of Physician Adherence to Guideline Recommendations for Life-saving Treatment in Heart Failure: an International Survey. , 2017, Cardiac failure review.

[3]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[4]  F. Leclercq,et al.  Multi-Marker Strategy in Heart Failure: Combination of ST2 and CRP Predicts Poor Outcome , 2016, PloS one.

[5]  A. Maggioni.  Epidemiology of Heart Failure in Europe. , 2015, Heart failure clinics.

[6]  M. Pfisterer,et al.  Which heart failure patients profit from natriuretic peptide guided therapy? A meta‐analysis from individual patient data of randomized trials , 2015, European journal of heart failure.

[7]  T. Mueller,et al.  Soluble ST2 in heart failure. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[8]  Y. Cavusoglu.  Predictors of survival in heart failure. , 2015, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[9]  Mark Woodward,et al.  Risk prediction in patients with heart failure: a systematic review and analysis. , 2014, JACC. Heart failure.

[10]  L. Lund,et al.  Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51 043 patients from the Swedish Heart Failure Registry , 2014, European journal of heart failure.

[11]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[12]  Michael Böhm,et al.  Predicting heart failure outcome from cardiac and comorbid conditions: the 3C-HF score. , 2013, International journal of cardiology.

[13]  Gerhard Hindricks,et al.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[14]  Jeroen J. Bax,et al.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. , 2012, European heart journal.

[15]  W. Kraus,et al.  Factors Related to Morbidity and Mortality in Patients With Chronic Heart Failure With Systolic Dysfunction: The HF-ACTION Predictive Risk Score Model , 2012, Circulation. Heart failure.

[16]  Jeffrey L. Anderson,et al.  2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Circulation.

[17]  Robert N. Doughty,et al.  The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. , 2011, European heart journal.

[18]  A. Cohen-Solal,et al.  Predictors of clinical outcomes in elderly patients with heart failure , 2011, European journal of heart failure.

[19]  V. Hasselblad,et al.  Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. , 2010, Journal of the American College of Cardiology.

[20]  A. Bayés‐Genís,et al.  Risk score : a simple method for predicting mortality in ambulatory patients with chronic heart failure , 2009 .

[21]  John G F Cleland,et al.  Predictors of fatal and non‐fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A‐1, high‐sensitivity C‐reactive peptide and N‐terminal pro B‐type natriuretic peptide , 2009, European journal of heart failure.

[22]  C. O'connor,et al.  Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). , 2008, American heart journal.

[23]  M. Jessup,et al.  A time to be born and a time to die. , 2007, Circulation.

[24]  D. Mozaffarian,et al.  The Seattle Heart Failure Model: Prediction of Survival in Heart Failure , 2006, Circulation.

[25]  J. Mao,et al.  Local infiltration with cocktail analgesics during 2 level lumbar spinal fusion surgery , 2019, Medicine.

[26]  Patrick Felicia,et al.  An International Survey , 2018 .

[27]  C. McCarthy,et al.  Soluble ST2 in Heart Failure. , 2018, Heart failure clinics.

[28]  M. Biddle,et al.  A report from the American Heart Association Council on Cardiovascular and Stroke Nursing. , 2015, The Journal of cardiovascular nursing.

[29]  J. Cowger,et al.  Heart failure prognostic models: why bother? , 2012, Circulation. Heart failure.

[30]  M. Cheitlin.  Predictors of mortality after discharge in patients hospitalized with heart failure: An analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) , 2009 .

[31]  Salim Yusuf,et al.  Predictors of mortality and morbidity in patients with chronic heart failure. , 2006, European heart journal.